mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.007 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |